A chemical company is developing a new process that can be used to create carbonate gels that can help solve a major problem in the food industry: hydrogen pollution.
The process involves creating hydrogen-filled carbonate solutions in a process called reverse osmosis.
The company, Terraform, has a new patent application for the process that could help solve the problem of food contamination that’s seen in the US.
While reverse ossification can be done to produce pure carbonate without creating any waste, there are many concerns about the impact on food quality.
A recent report from the Food and Drug Administration found that over 70% of foodborne illness outbreaks in the United States are due to hydrogen contamination, and it can take up to three months for a single contaminated food to have an impact on the health of its consumer.
But reverse osis is a lot cheaper than making pure carbonates, and the process could help ease some of the problems that come with the manufacturing process.
“This new technology can dramatically reduce the time it takes for the carbonate to get from the carbonic acid in the electrolyte to the carbon dioxide, and that reduces the amount of time it will take for a consumer to find the source of contamination,” says Jason Smith, Terraformed’s president and CEO.
“This process can eliminate the need for expensive testing, and could also eliminate the cost of food quality inspection.”
Terraform’s process could also allow the company to use hydrogen as a substitute for chlorine in many products, which are now made with chlorine.
As a result, Terraforming could reduce the amount hydrogen produced in food by 50%, or more, according to the company.
According to the patent, TerraForm will work with the Department of Defense and other government agencies to develop a prototype that could be commercially available by the end of the year.
For now, Terraforms process could only be used for food manufacturing and research purposes, but the company says it’s looking at potential uses for its process in the healthcare and pharmaceutical industries.
Follow Michael on Twitter.
Follow Tech Insider: